Revvity, Inc. (NYSE:RVTY) Shares Sold by US Asset Management LLC

US Asset Management LLC decreased its position in Revvity, Inc. (NYSE:RVTY) by 3.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,848 shares of the company’s stock after selling 130 shares during the quarter. US Asset Management LLC’s holdings in Revvity were worth $404,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Federated Hermes Inc. raised its position in Revvity by 7.5% in the second quarter. Federated Hermes Inc. now owns 190,030 shares of the company’s stock worth $19,927,000 after acquiring an additional 13,203 shares in the last quarter. DekaBank Deutsche Girozentrale raised its holdings in shares of Revvity by 1.3% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 85,502 shares of the company’s stock worth $8,985,000 after purchasing an additional 1,119 shares in the last quarter. Qsemble Capital Management LP lifted its stake in Revvity by 13.8% during the second quarter. Qsemble Capital Management LP now owns 9,137 shares of the company’s stock valued at $958,000 after purchasing an additional 1,108 shares during the last quarter. Daiwa Securities Group Inc. boosted its holdings in Revvity by 6.9% during the second quarter. Daiwa Securities Group Inc. now owns 21,828 shares of the company’s stock worth $2,289,000 after buying an additional 1,404 shares in the last quarter. Finally, Choreo LLC bought a new stake in Revvity during the second quarter worth approximately $328,000. Institutional investors own 86.65% of the company’s stock.

Revvity Trading Up 1.6 %

Shares of RVTY stock opened at $122.03 on Friday. The firm has a market capitalization of $15.05 billion, a P/E ratio of 100.85, a price-to-earnings-growth ratio of 2.87 and a beta of 1.05. Revvity, Inc. has a 1 year low of $79.50 and a 1 year high of $128.15. The firm’s fifty day simple moving average is $117.37 and its 200 day simple moving average is $110.01. The company has a current ratio of 2.27, a quick ratio of 1.98 and a debt-to-equity ratio of 0.40.

Revvity (NYSE:RVTY) last posted its quarterly earnings data on Monday, July 29th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.12 by $0.10. Revvity had a net margin of 6.26% and a return on equity of 7.34%. The company had revenue of $691.70 million for the quarter, compared to the consensus estimate of $690.33 million. During the same quarter in the previous year, the firm posted $1.21 EPS. The business’s revenue was down 2.5% compared to the same quarter last year. As a group, sell-side analysts predict that Revvity, Inc. will post 4.75 EPS for the current year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 8th. Investors of record on Friday, October 18th will be given a $0.07 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $0.28 annualized dividend and a yield of 0.23%. Revvity’s dividend payout ratio (DPR) is currently 23.14%.

Insiders Place Their Bets

In related news, insider Joel S. Goldberg sold 3,500 shares of the company’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $117.86, for a total value of $412,510.00. Following the sale, the insider now owns 33,400 shares of the company’s stock, valued at $3,936,524. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the company. Barclays increased their price objective on Revvity from $115.00 to $125.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 30th. Leerink Partnrs upgraded Revvity to a “strong-buy” rating in a research report on Monday, July 8th. Leerink Partners assumed coverage on Revvity in a report on Monday, July 8th. They set an “outperform” rating and a $125.00 price objective on the stock. Jefferies Financial Group raised their target price on shares of Revvity from $115.00 to $125.00 and gave the stock a “hold” rating in a report on Monday, July 29th. Finally, TD Cowen boosted their price target on shares of Revvity from $130.00 to $141.00 and gave the company a “buy” rating in a report on Tuesday, July 30th. Eight analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, Revvity presently has an average rating of “Moderate Buy” and a consensus price target of $126.00.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.